financetom
Business
financetom
/
Business
/
Pinterest shares jump as AI advertisement tools drive forecasts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pinterest shares jump as AI advertisement tools drive forecasts
Feb 7, 2025 7:15 AM

(Reuters) - Pinterest's ( PINS ) shares rose 20% on Friday as it forecast first-quarter revenue above estimates, indicating that its AI-powered tools would spur ad spend on the image sharing platform.

Pinterest ( PINS ) has focused on direct response ads, designed to prompt specific actions like app downloads or website visits.

Investments in AI tools such as its Performance+ suite for improving targeting of ads with automation are also helping Pinterest ( PINS ). CEO Bill Ready said advertisers that were using these tools required 50% fewer inputs to create a campaign now.

"If you're a smaller ad platform, the less time and more automated you can make it for the advertisers, the easier it is to get them to try you out," Bernstein analyst Mark Shmulik said.

"We think the progress Pinterest ( PINS ) has shown is sustainable."

The social media firm also posted record revenue in the fourth quarter as strength in advertising from retail, technology and financial services sectors offset the ongoing weakness in marketing spend from food and beverage.

At least 27 brokerages raised their price target on Pinterest ( PINS ) after its latest earnings report.

The company is set to add more than $4 billion in its market value if gains hold. As of last close, it had a market valuation of $22.70 billion.

Pinterest's ( PINS ) shares often react wildly after its earnings reports. They dropped 14% after the company's weak holiday quarter forecast in November, but the stock rose 21% a day after it reported first quarter results in April last year.

The company's first-quarter revenue forecast of $837 million to $852 million was above analysts' average estimate of $832.8 million, according to data compiled by LSEG.

Its adjusted core earnings forecast of $155 million to $170 million was also ahead of analysts' estimates.

In the fourth quarter, revenue of $1.15 billion was slightly ahead of estimates. Global monthly active users were 553 million.

Pinterest ( PINS ) currently trades at 17.88 times the estimates of its earnings for the next 12 months, compared with 27.37 times for Meta and Snap's 25.40 times.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Leidos to Collaborate With Amazon's AWS to Develop New Products, Services
Leidos to Collaborate With Amazon's AWS to Develop New Products, Services
Mar 6, 2024
09:08 AM EST, 03/06/2024 (MT Newswires) -- Leidos Holdings ( LDOS ) , a security and engineering company, said Wednesday that it has signed a collaboration agreement with Amazon's ( AMZN ) cloud computing platform Amazon Web Services, or AWS, to develop new go-to-market products and services. Leidos ( LDOS ) said the agreement calls for it to combine its...
U S Physical Therapy Inc /nv Insider Sold Shares Worth $274,441, According to a Recent SEC Filing
U S Physical Therapy Inc /nv Insider Sold Shares Worth $274,441, According to a Recent SEC Filing
Mar 6, 2024
09:11 AM EST, 03/06/2024 (MT Newswires) -- Graham D. Reeve, COO, on March 04, 2024, sold 2,629 shares in U S Physical Therapy Inc /nv (USPH) for $274,441. Following the Form 4 filing with the SEC, Reeve has control over a total of 25,162 shares of the company, with 18,260 shares held directly and 6,902 shares controlled indirectly. SEC Filing:...
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
Mar 6, 2024
Tuesday, the FDA approved DexCom Inc’s Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM).  The Dexcom Stelo Glucose Biosensor System is an integrated CGM (iCGM) intended for anyone 18 years and older who does not use insulin. The company said Stelo will be available online without a prescription starting summer of 2024. This system is not for individuals with...
Gilead Sciences, Merus Collaborate to Discover New Potential Cancer Therapies
Gilead Sciences, Merus Collaborate to Discover New Potential Cancer Therapies
Mar 6, 2024
09:10 AM EST, 03/06/2024 (MT Newswires) -- Gilead Sciences ( GILD ) and Merus (MRUS) said Wednesday they have signed a research collaboration, option, and license agreement to discover and market novel T-cell engager antibodies. The companies said Gilead will bring its oncology expertise and Merus its Triclonics platform to research and develop multiple, separate preclinical research programs for novel...
Copyright 2023-2026 - www.financetom.com All Rights Reserved